Accretion Nutraveda logo

Accretion Nutraveda financials and balance sheet

BSE: 544694Pharmaceuticals & BiotechnologySmall Cap

Last close ₹273.25down ₹21.75 (7.37%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹295.00.

Range of traded prices from listing on 4 Feb 2026 to 23 Oct 2026
₹150.10Low, 12 Feb 2026₹313.00High, 24 Aug 2026
Market cap
₹198 Cr2,550th largest listed
P/E
39.0
P/B
5.6
Dividend yield
Nonesince listing in Feb 2026
ROE
14.3%
Debt to equity
0.12
Volume, BSE
3,000

1 year at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Accretion Nutraveda annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue34
  2. Materials and goods−24
  3. Employee costs−1.1
  4. Other expenses−1.5
  5. Operating profit6.9
  6. Depreciation−0.3
  7. Other income+0.1
  8. Finance costs−0.5
  9. Profit before tax6.2
  10. Tax−1.1
  11. Net profit5.1

What the company owns

  • Plant, investments and other assets₹23 Cr
  • Inventory₹9 Cr
  • Receivables₹8 Cr
  • Cash and bank₹1 Cr

What pays for it: net worth and liabilities

  • Net worth₹35 Cr
  • Borrowings₹4 Cr
  • Other liabilities₹1 Cr
  • Owed to suppliers₹1 Cr

Profit and loss

Standalone, ₹ crore, years to March.Accretion Nutraveda half-yearly results

₹ croreMar 2026Filed 8 May
Revenue from operations33.6
26.7
Materials and goods bought24.1
Employee costs1.1
Other expenses1.5
Operating profit before depreciation6.9
Operating margin20.5%
Materials, % of revenue71.7%
Employee costs, % of revenue3.2%
Other expenses, % of revenue4.6%
Depreciation and amortisation0.3
Operating profit after depreciation6.6
Other income0.1
Finance costs0.5
Profit before tax6.2
1.1
Net profit5.1
Net margin15.1%

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2026Filed 8 May
35.5
Share capital7.2
Reserves28.2
4.2
2.5
Liabilities due after a year3.8
Total assets41.8
5.6
36.2
Net debt3.0
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2026Filed 8 May
−23.9
−22.8
−29.7
Receivables−4.8
Inventories−4.4
Payables0.0
Other working capital−20.5
Tax paid−1.1
Capital spending0.1
Free cash flow−24.0
Cash from investing−0.1
25.3
Dividends paid0.0
Shares issued25.4
Net change in cash1.3
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2026Filed 8 May
Earnings per share₹9.35
Diluted earnings per share₹9.35
Book value per share₹49.00
Shareholder yield−16.8%
Market cap at the year end (₹ crore)151

Ratios

Standalone, years to March.Accretion Nutraveda PE ratio and valuation

RatioMar 2026Filed 8 May
Return on equity14.3%
Return on capital employed16.7%
Cash conversion−472.0%
Interest cover12.4
Debt to equity0.12
Receivable days88
Inventory days136
Payable days14
Cash conversion cycle, days211
Working capital days357
Asset turnover0.80
Assets per rupee of net worth1.18
Sales per rupee of plant20.29
Capital spending to depreciation0.32

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
12.1%
Cash from operations against operating profit
−347.1%

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations−23.9
Cash from investing−0.1
Cash from financing25.3
Capital spending0.1
Dividends paid0.0
Shares issued for cash25.4
Borrowings raised1.3
Borrowings repaid1.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2026
Effective tax ratePublished threshold 17.16 per cent18.40
Tax charged less tax paid, % of profitOur threshold 10 percentage points0.05
A threshold marked as ours has no published figure; it is the line we read the check against.